Conferences : [5723]
Collection home page

Conference papers, abstracts, posters, or presentations.

Browse
in this collection
Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed RSS Feed RSS Feed
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 5723
 next >
PreviewIssue DateTitleAuthor(s)
12-Mar-2025Machine learning for cardiac death prediction after myocardial infarction: the power of echocardiographic data.Scanlon L.; Prasad S.; Lin A.; Vollbon W.; Parsonage W.; Atherton J.
13-Mar-2025Predicting the likelihood of coronary revascularisation in a suspected acute coronary syndrome, in the era of machine learning.Seneviratne D.; Goel V.; Scanlon L.; Lin A.; Chew D.P.
12-Mar-2025Cardiovascular risk assessment in patients commenced on androgen deprivation therapy for prostate cancer - under-recognised and under-treated?Pathak U.; Tan S.; Pook D. ; Ramkumar S.
12-Mar-2025Machine learning integration of clinical and echocardiographic data predicts long-term survival following myocardial infarction.Scanlon L.; Lin A.; Prasad S.; Vollbon W.; Parsonage W.; Atherton J.
12-Mar-2025Complete percutaneous revascularization in stemi patients with multivessel disease: a meta-analysis and meta-regression of contemporary randomized trials.Goel V.; Scanlon L.; O'Brien J.M.; Paleri S.; Vasanthakumar S.; Stub D.; Chew D.P.; Nerlekar N. ; Brown A.J.
8-Mar-2025Activation of the geste antagoniste improves speed of finger tapping in organic and functional dystonia.Newby R.E.; Muhamed S.; Smith S.; Alty J.E.; Jamieson S.; Kempster P.A.
12-Mar-2025Alpha-1 antitrypsin and deoxyribonuclease 1 as potential therapies for the treatment of bronchiectasis.King P. 
7-Mar-2025POS1189 the impact of telemedicine and COVID-19 on a tertiary rheumatology service: a retrospective audit.Zhu W.; De Silva T.; Eades L.; Morton S.; Ayoub S. ; Morand E.F. ; Antony A. 
7-Mar-2025POS0691 effects of anifrolumab on renal disease in patients with SLE.Morand E.F. ; Furie R.; Tanaka Y.; Takeuchi T.; Abreu G.; Tummala R.; Lindholm C.
7-Mar-2025POS0683 novel stringent outcome measures applied to the phase 2 and 3 anifrolumab trials.Isenberg D.; Bruce I.N.; Furie R.; Morand E.F. ; Tanaka Y.; Manzi S.; Kalunian K.; Psachoulia K.; Maho E.; Tummala R.
12-Mar-2025'You are as frail as your arteries''exploring the correlation between frailty, and chronological and vascular age parameters.Mukhopadhyay R.; Mensah E.; Kirkham F.-A.; Shwe P.S. ; Ali K.; Rajkumar C.
21-Feb-2025TCT-257 impact of diabetes on coronary artery disease patterns and PCI outcomes.Munhoz D.; Tajima A.; Storozhenko T.; Mizukami T.; Sonck J.; Matsuo H.; Ando H.; Ko B. ; Biscaglia S.; Rivero F.; Engstroem T.; Leone A.M.; van Nunen L.; Fearon W.; Christiansen E.; Fournier S.; Desta L.; Yong A.; Adjedj J.; Escaned J.; Nakayama M.; Eftekhari A.; zimmermann F.; Sakai K.; da Costa B.; Campo G.; Berry C.; Collison D.; Johnson T.; Amano T.; Perera D.; Jeremias A.; Ali Z.; Pijls N.; de Bruyne B.; Johnson N.; Collet C.
20-Feb-2025Variation in healthcare utilisation amongst IBD care centres in Australia and New Zealand, Crohn's Colitis Care Data Insight's Program.Su W.K.; Wilson W.; Wark G.; Walker G.; Su H.; Forbes A.; Kim A.; Giles E. ; Lawrance I.; Dutt S.; Brett L.; Begun J.; Lynch K.; Andrews J.M.; Connor S.J.
20-Feb-2025Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study.Kim S.J.; Kim D.H.; Park S.H.; Kim K.O.; Jang B.I.; Kim D.S.; Lee Y.J.; Song E.M.; Lee H.S.; Kim E.S.; Yang C.H.; Sagami S.; Kobayashi T.; Mak J.; Liu J.; Cao Q.; Lin C.C.; Lin W.C.; Hsu W.G.; Wei S.C.; Rice K.; An Y.K.; Begun J.; Ruddick-Collins L.; Fernandes R.G.; Robert G.; Vasudevan A.; Zhang J.; Brownson A.; Ngoi B.; Kate L.; Haifer C.; Bracken L.M.L.; Swe E.; Wright E.; Clark N.; Schildkraut T.; Mahy G.; Moore G. ; Garg M.
20-Feb-2025Infra-red microspectroscopy provides quantitative assessment of fibro-inflammation in Crohn's disease strictures and predicts post-operative recurrence.Keung C. ; Pawlowski R.; Ryan A.; Kwan E. ; Longano A.; Lim R.; Sievert W. ; Moore G.T.; Wood B.
20-Feb-2025A precision medicine approach for carriers of defined IL2RA polymorphism: JAK inhibition blocks exaggerated IL-2 signalling in vitro, with no difference in in vivo clinical response rates in a small clinical cohort.Clough J.; Honap S.; Centritto A.; Seah D.; Jayasena H.; Irving P.; Lord G.
20-Feb-2025Geographic disparities in Healthcare Utilisation in people with inflammatory bowel disease, Crohn's Colitis Cure Data Insights Program.Su W.K.; Wilson W.; Ng W.; Su H.; Forbes A.; Walker G.; Kim A.; Giles E. ; Lawrance I.; Dutt S.; Brett L.; An Y.K.; Lynch K.; Connor S.J.; Andrews J.M.
20-Feb-2025Predicting response to anti-tumour necrosis factor-alpha therapy-alpha in fibrostenotic Crohn's disease using infra-red microspectroscopy.Keung C. ; Correia J.; Longano A.; Schulberg J.D.; Wright E.K.; Hamilton A.L.; Kamm M.A.; Lim R.; Sievert W. ; Wood B.; Moore G.T.
20-Feb-2025The role of bound anti-drug antibodies to infliximab in predicting future immunogenic failure when de-escalating from combination therapy with an immunomodulator to anti-TNF monotherapy (RAPIDIM Study).Cameron K.; Sam M.; Theena N.; Gu B.; Arzivian A.; Skinner T.; Shelton E.; Connor S.J.; Toong C.; Gibson P.R.; Gibson D.J.; Sparrow M.P.; Ward M.G.
20-Feb-2025High prevalence of HLA DRB1*01:03 in Australian inflammatory bowel disease patients without prediction of refractory disease.Peterson A.; Zorkau I.; Liu Y.; Tan E.T.; Lee M.; Moore G. ; Ooi J.; Goldberg R.
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 5723
 next >

Date issued